Weiqiang Medtech

Suzhou Weiqiang Medical Technology (Weiqiang Medtech) is a leading Chinese medical device company focused on the development of minimally invasive interventional solutions for vascular diseases. The company specializes in neurovascular and peripheral vascular interventions, offering a robust portfolio of NMPA-approved products including embolic coils, intracranial stents, and thrombectomy systems. Founded in 2014 and headquartered in the Suzhou Industrial Park, Weiqiang Medtech leverages advanced manufacturing and R&D capabilities to provide high-quality alternatives to imported medical devices. Their flagship products, such as the V-COIL embolic system and V-pass stent retriever, are widely utilized in clinical settings for the treatment of hemorrhagic and ischemic strokes. The company is supported by top-tier investors like Sequoia China and IDG Capital, positioning it as a key player in China's rapidly growing interventional medtech sector.